Updated trends in US brand-name and generic drug competition
Repository Usage Stats
Published Version (Please cite this version)10.1080/13696998.2016.1176578
Publication InfoBoyo, A; Grabowski, Henry G; Long, Genia; & Mortimer, R (2016). Updated trends in US brand-name and generic drug competition. Journal of Medical Economics, 19(9). pp. 836-844. 10.1080/13696998.2016.1176578. Retrieved from https://hdl.handle.net/10161/12738.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
More InfoShow full item record
Professor Emeritus of Economics
Professor Grabowski specializes in the investigation of economics in the pharmaceutical industry, government regulation of business, and the economics of innovation. His specific interests within these fields include intellectual property and generic competition issues, the effects of government policy actions, and the costs and returns to pharmaceutical R&D. He has been publishing research papers for over four decades, from his earlier work, “The Effects of Regulatory Policy on the Incentives
Professor of Medicine
1. High dose therapy and autologous and allogeneic stem cell rescue for hematologic malignancies (especially multiple myeloma) and solid tumors. 2. Non-myeloablative allogeneic transplants for hematologic malignancies and solid tumors. 3. Supportive care for hematopoietic stem cell transplants. 4. Prevention and therapy of graft versus host disease.
Alphabetical list of authors with Scholars@Duke profiles.